Structures by: Mao P.
Total: 23
Dibromido[<i>N</i>-(1-diethylamino-1-oxo-3-phenylpropan-2-yl)-<i>N</i>'-(pyridin-2-yl)imidazol-2-ylidene]palladium(II) dichloromethane monosolvate
C21H24Br2N4OPd,CH2Cl2
IUCrData (2019) 4, 7 x190899
a=17.6670(4)Å b=12.8871(3)Å c=11.7476(3)Å
α=90° β=90° γ=90°
3-Benzoyl-7-methoxy-2<i>H</i>-chromen-2-one
C17H12O4
IUCrData (2017) 2, 3 x170373
a=4.07206(11)Å b=11.9589(3)Å c=27.5626(7)Å
α=90° β=90.306(2)° γ=90°
Dimethyl (7-hydroxy-4-methyl-2-oxo-2<i>H</i>-chromen-3-yl)phosphonate
C12H13O6P
IUCrData (2017) 2, 8 x171119
a=9.9684(7)Å b=7.8695(6)Å c=16.6927(10)Å
α=90° β=106.097(7)° γ=90°
C37H48N2OPScSi2
C37H48N2OPScSi2
Dalton Transactions (2020)
a=10.8334(3)Å b=28.3891(8)Å c=13.0622(4)Å
α=90° β=109.6730(10)° γ=90°
C35H52.5N2O2SSi2Y
C35H52.5N2O2SSi2Y
Dalton Transactions (2020)
a=10.9957(3)Å b=11.6568(3)Å c=14.7462(4)Å
α=86.602(2)° β=83.774(2)° γ=85.085(2)°
C37H48N2OPSi2Y
C37H48N2OPSi2Y
Dalton Transactions (2020)
a=10.9462(4)Å b=28.3973(10)Å c=13.2216(4)Å
α=90° β=109.9930(10)° γ=90°
C37H48LuN2OPSi2
C37H48LuN2OPSi2
Dalton Transactions (2020)
a=10.8990(4)Å b=28.3514(11)Å c=13.1599(5)Å
α=90° β=109.8640(10)° γ=90°
C17H17Br2N3OPd
C17H17Br2N3OPd
RSC Adv. (2015)
a=5.7083(3)Å b=12.8910(6)Å c=12.3640(6)Å
α=90.00° β=92.415(5)° γ=90.00°
C16H16Cl2N4OPd
C16H16Cl2N4OPd
RSC Adv. (2015)
a=10.6261(3)Å b=11.4231(3)Å c=14.4936(3)Å
α=90.00° β=90.00° γ=90.00°
F6P,C18H23N4
F6P,C18H23N4
RSC Adv. (2015)
a=9.6098(2)Å b=11.4528(4)Å c=18.8441(5)Å
α=90.00° β=90.00° γ=90.00°
C18H22ClN4Pd,F6P
C18H22ClN4Pd,F6P
RSC Adv. (2015)
a=7.8169(4)Å b=12.9702(6)Å c=22.3383(10)Å
α=90.00° β=90.00° γ=90.00°
3-Mesityl-1-[(pyridin-2-yl)methyl]-3,4,5,6-tetrahydropyrimidin-1-ium bromide monohydrate
C19H24N3,Br,H2O
Acta Crystallographica Section E (2015) 71, 4 o224
a=15.5868(5)Å b=14.6323(4)Å c=17.0439(6)Å
α=90.00° β=90.00° γ=90.00°
Dibromidobis[1-(2,4,6-trimethylphenyl)-1,4,5,6-tetrahydropyrimidine- κ<i>N</i>^3^]palladium(II)
C26H36Br2N4Pd
Acta Crystallographica Section E (2011) 67, 1 m62
a=7.1348(14)Å b=21.308(4)Å c=8.9704(18)Å
α=90.00° β=94.60(3)° γ=90.00°
2-(4,5-Diphenyl-2-<i>p</i>-tolyl-1<i>H</i>-imidazol-1-yl)-3-phenylpropan-1-ol
C31H28N2O
Acta Crystallographica Section E (2012) 68, 2 o264
a=9.3413(7)Å b=13.7402(11)Å c=19.6296(14)Å
α=90.00° β=90.00° γ=90.00°
2-[2-(2-Nitrophenyl)-4,5-diphenyl-1<i>H</i>-imidazol-1-yl]-3-phenylpropan-1-ol
C30H25N3O3
Acta Crystallographica Section E (2014) 70, 5 o621
a=10.54812(16)Å b=12.77836(19)Å c=18.4800(3)Å
α=90.00° β=90.00° γ=90.00°
2-[4,5-Diphenyl-2-(pyridin-2-yl)-1<i>H</i>-imidazol-1-yl]-3-phenylpropan-1-ol
C29H25N3O
Acta Crystallographica Section E (2012) 68, 6 o1670
a=9.2695(4)Å b=15.8818(6)Å c=16.0498(6)Å
α=90.00° β=90.00° γ=90.00°
2-[2-(5-Bromothiophen-2-yl)-4,5-diphenyl-1<i>H</i>-imidazol-1-yl]-3-phenylpropan-1-ol
C28H23BrN2OS
Acta Crystallographica Section E (2013) 69, 9 o1379
a=9.36677(18)Å b=15.8434(3)Å c=16.1452(3)Å
α=90.00° β=90.00° γ=90.00°
1,1'-Methylenebis[3-(2,6-diisopropylphenyl)-3,4,5,6-tetrahydropyrimidin-1-ium] dibromide ethanol monosolvate monohydrate
C33H50N42,2(Br),C2H6O,H2O
Acta Crystallographica Section E (2013) 69, 9 o1377-o1378
a=13.6267(4)Å b=10.3769(2)Å c=26.9387(6)Å
α=90.00° β=91.361(2)° γ=90.00°
(<i>S</i>)-4,5-Diphenyl-1-[1-phenyl-3-(phenylsulfanyl)propan-2-yl]-2-(thiophen-2-yl)-1<i>H</i>-imidazole
C34H28N2S2
Acta Crystallographica Section E (2013) 69, 12 o1858
a=12.7882(7)Å b=13.7906(6)Å c=16.0636(7)Å
α=90.00° β=90.00° γ=90.00°
1-[(2<i>S</i>)-1-Chloro-3-phenylpropan-2-yl]-2,4,5-triphenyl- 1<i>H</i>-imidazole
C30H25ClN2
Acta Crystallographica Section E (2012) 68, 4 o1153
a=9.6123(4)Å b=9.9437(3)Å c=24.9677(7)Å
α=90.00° β=90.00° γ=90.00°
C24H19NO2
C24H19NO2
The Journal of organic chemistry (2014) 79, 17 8094-8102
a=9.5219(5)Å b=9.7304(8)Å c=11.5747(9)Å
α=105.945(7)° β=109.988(6)° γ=99.912(6)°
C23H16BrNO2
C23H16BrNO2
The Journal of organic chemistry (2014) 79, 17 8094-8102
a=10.3678(4)Å b=9.9254(3)Å c=18.3510(6)Å
α=90.00° β=104.086(4)° γ=90.00°